This, they believe, is because the electorate votes differently in state and general elections. On their part, the markets, they said, are only looking for a stable regime and policy continuity.
The UK operations suffered from low steel prices as well as higher costs on the emission rights front
Closing Bell on September 13, 2023:The gains were led by Bharti Airtel (up 2.7 per cent), Titan, Axis Bank, SBI, IndusInd Bank, Power Grid, NTPC, Tata Motors, Ultratech Cement, and Bajaj Finance
Shares related to Chandrayaan-3 may rise up to 15 per cent in the upcoming sessions, as per their respective technical chart patterns
Barring Cummins India, which did perform in the current year but the present structure shows sluggishness; all other stocks included in MSCI index are poised for the next bull-run.
Post Q1 results, major banking stocks have lost the upside bias. Most stocks are facing hurdles at upper levels.
While the trend looks fragile, key supports are continuing to bolster the up move
Stocks to Watch on Tuesday, August 1, 2023: The Board of ITC will meet on August 14 to announce Q1FY24 results, and consider the Scheme of Arrangement for the demerger of Hotels Business
Barring, Pfizer, Gland Pharma, and Laurus Labs, all other constituents of Nifty Pharm Index trade over the 200-day simple moving average (SMA),
Trend in Bajaj twins remains sluggish and may slide in bear's grip if key levels are breached
Technical charts of M&M shows weakness, while RBL Bank continues to remain resilient.
The FMCG index has breached previous reversal support, igniting fear of caution among retail traders. This move emerged after the index reached a new historic peak a few sessions ago.
While the medium-term outlook remains highly optimistic, the stock may remain choppy in the near-term
ICICI Bank remains strong on charts post delivering Q1 results last week
Listed NBFC stocks are currently facing selling pressure at higher levels, show technical charts
The range breakout in both the indices have triggered fresh upside
Technically, when any stocks crosses crucial hurdles and witnesses accumulation at key supports, the trend is expected to witness robust upside ahead.
The counter may struggle to cross Rs 2,800-mark, which appears to be the next hurdle, but the current momentum is not suggesting any weakness.
Market participants closely monitor the RSI to determine the strength based on 70 and 30 values. This assists in identifying instruments that are supposedly experiencing increased buying or selling.
Pharm index has broken out on upside, with the positive rally anticipated to hit 14,450